Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
RCU for Lifestyle Interventions in Overweight and Obese Pregnant Women Consortium
Lebanon-Epidemiology: The NCS Replication Study
National Comorbidity Survey - Replication (NCS-R)
Improving Effectiveness of the Tb Prevention & Control Program in Estonia
Research Initiation Award: Fast Solvers for Variable-Coefficient Poroelastic Models
Recently added grants:
Investigating the molecular requirements for ESX-1-lytic activity in pathogenic mycobacteria
Elucidating ecological mechanisms for propagation of antibiotic resistance genes via massively parallelized single-cell sequencing
Modulation and Utilization of RNA Polymerase III by Herpes Simplex Virus
Primary Aldosteronism Subtypes: Pathophysiology and Steroid Signatures
Developing a set of robust tools to interrogate Legionella effector function
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35157-6-0-1
Application #
7575955
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/ Northwestern University at Chicago
$1,704,878
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Bergan, Raymond C. /
$1,602,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant